The impact of TNFSF14 on prognosis and immune microenvironment in clear cell renal cell carcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The impact of TNFSF14 on prognosis and immune microenvironment in clear cell renal cell carcinoma
Authors
Keywords
-
Journal
Genes & Genomics
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-28
DOI
10.1007/s13258-020-00974-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of heterogeneous regulatory T cells in the tumor microenvironment
- (2020) Ting Wei et al. PHARMACOLOGICAL RESEARCH
- Mining TCGA database for tumor mutation burden and their clinical significance in bladder cancer
- (2020) Jia Lv et al. BIOSCIENCE REPORTS
- Comprehensive bioinformatics analysis identifies tumor microenvironment and immune-related genes in small cell lung cancer
- (2020) Yongchun Song et al. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
- Very low intensity ultrasounds as a new strategy to improve selective delivery of nanoparticles-complexes in cancer cells
- (2019) Rossella Loria et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Tumor mutational load predicts survival after immunotherapy across multiple cancer types
- (2019) Robert M. Samstein et al. NATURE GENETICS
- Building on the anti-PD1/PD-L1 Backbone: Combination Immunotherapy for Cancer
- (2019) Alvaro H Ingles Garces et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Predicting Renal Cancer Recurrence: Defining Limitations of Existing Prognostic Models With Prospective Trial-Based Validation
- (2019) Andres F. Correa et al. JOURNAL OF CLINICAL ONCOLOGY
- LIGHT/TNFSF14 Promotes Osteolytic Bone Metastases in Non‐small Cell Lung Cancer Patients
- (2019) Giacomina Brunetti et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Biomarkers of Prognosis and Efficacy of Anti-angiogenic Therapy in Metastatic Clear Cell Renal Cancer
- (2019) Carmine D'Aniello et al. Frontiers in Oncology
- Vascular targeting of LIGHT normalizes blood vessels in primary brain cancer and induces intratumoural high endothelial venules
- (2018) Bo He et al. JOURNAL OF PATHOLOGY
- Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
- (2018) T A Chan et al. ANNALS OF ONCOLOGY
- Cytoscape StringApp: Network Analysis and Visualization of Proteomics Data
- (2018) Nadezhda T. Doncheva et al. JOURNAL OF PROTEOME RESEARCH
- The TNF Family of Ligands and Receptors: Communication Modules in the Immune System and Beyond
- (2018) Catherine Dostert et al. PHYSIOLOGICAL REVIEWS
- Immunotherapy for Urothelial Carcinoma: Current Evidence and Future Directions
- (2018) Abhishek Tripathi et al. Current Urology Reports
- Systemic Therapy for Metastatic Renal-Cell Carcinoma
- (2017) Toni K. Choueiri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
- (2017) Zachary R. Chalmers et al. Genome Medicine
- Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
- (2016) Jonathan E Rosenberg et al. LANCET
- Understanding Pathologic Variants of Renal Cell Carcinoma: Distilling Therapeutic Opportunities from Biologic Complexity
- (2015) Brian Shuch et al. EUROPEAN UROLOGY
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Genetic Evidence That Intratumoral T-cell Proliferation and Activation Are Associated with Recurrence and Survival in Patients with Resected Colorectal Liver Metastases
- (2015) A. V. Maker et al. Cancer Immunology Research
- Precise identification of immunotherapeutic targets for solid malignancies using clues within the tumor microenvironment—Evidence to turn on the LIGHT
- (2015) Ajay V. Maker OncoImmunology
- Forced LIGHT expression in prostate tumors overcomes Treg mediated immunosuppression and synergizes with a prostate tumor therapeutic vaccine by recruiting effector T lymphocytes
- (2014) Lisa Yan et al. PROSTATE
- Interleukin-30 Expression in Prostate Cancer and Its Draining Lymph Nodes Correlates with Advanced Grade and Stage
- (2013) Serena Di Meo et al. CLINICAL CANCER RESEARCH
- Shedding LIGHT (TNFSF14) on the tumor microenvironment of colorectal cancer liver metastases
- (2013) Jian Zhong Qin et al. Journal of Translational Medicine
- Lentivirus-mediated LIGHT overexpression inhibits human colorectal carcinoma cell growth in vitro and in vivo
- (2013) HAIBO WANG et al. Oncology Letters
- Withaferin A inhibits JAK/STAT3 signaling and induces apoptosis of human renal carcinoma Caki cells
- (2012) Hee Jung Um et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Recruitment of monocytes/macrophages in different tumor microenvironments
- (2012) Heon-Woo Lee et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Gene therapy of gastric cancer using LIGHT-secreting human umbilical cord blood-derived mesenchymal stem cells
- (2012) Xinhong Zhu et al. Gastric Cancer
- Human Blood CXCR5+CD4+ T Cells Are Counterparts of T Follicular Cells and Contain Specific Subsets that Differentially Support Antibody Secretion
- (2011) Rimpei Morita et al. IMMUNITY
- Expression of LIGHT/TNFSF14 Combined with Vaccination against Human Papillomavirus Type 16 E7 Induces Significant Tumor Regression
- (2010) S. Kanodia et al. CANCER RESEARCH
- A role for HVEM, but not lymphotoxin-β receptor, in LIGHT-induced tumor cell death and chemokine production
- (2009) Christine Pasero et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Targeting tumors with LIGHT to generate metastasis-clearing immunity
- (2008) Ping Yu et al. CYTOKINE & GROWTH FACTOR REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started